Overview

EAA/Therapy for Treating Children With ADHD

Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is 1) to investigate clinical effects of equine-assisted activities and therapy (EAA/T) for treating attention-deficit/hyperactivity disorder (ADHD) and 2) to compare the clinical effect of EAA/T and drug therapy in children 6-13-years-of-age. This study is designed as a 12-week, prospective, open labeled trial, including 24 sessions of EAA/T. Forty six subjects will be enrolled and various clinical tests will be administered at baseline and after EAA/T or drug therapy.
Phase:
N/A
Details
Lead Sponsor:
Samsung Medical Center
Collaborator:
Samsung Electronics
Treatments:
Atomoxetine Hydrochloride
Methylphenidate